- Trump Team Claims Successes Against ACA Fraud While Pushing for More Controls
- Give and Take: Federal Rural Health Funding Could Trigger Service Cuts
- Where are you with EUDAMED?
- Where are you with EUDAMED?
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- HL7 Launches Real‑Time Medical Device Interoperability Accelerator
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Two GA Tech ATDC Startups — Nephrodite and OrthoPreserve — Secure FDA Breakthrough Device Designation
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Artificial Intelligence: ROI, not Clinical Autonomy, Leads Operational Workflows
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Medtronic and Merit Medical Systems distribution agreement for new, ViaVerte basivertebral nerve ablation system
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- Breakthrough Device Designation for Noah Labs Vox Heart Failure Detection Device
- No more ‘old school’: How Duke Health is reimagining workforce development
- Why private practice dentistry needs a better model
- Chief nurses: Hospital finances improve with nursing investments
- Mississippi health system goes ‘all in’ on Epic with $115M investment
- CareQuest Innovation Partners, Kno2 collab on medical-dental data integration
- Ascension Wisconsin CEO to step down
- The hospitals, health systems cutting jobs in 2026
- Nonprofit highlights rural opioid care strategies
- The 7 things on the table in the Mount Sinai-Anthem negotiations
- Wearables data predicts patient engagement: Mayo Clinic study
- Advocate plans largest US hospital drone delivery network
- Vitana Pediatric & Orthodontic Partners adds Florida practice
- Indiana system opens $21.7M outpatient center
- Trump administration targets medical school admissions: 4 notes
- EyeSouth Partners continues 2026 expansion with Louisiana practice
- RSV lingers in parts of US even as flu and COVID-19 recede
- A huge month for CMS policy
- What the Health? From KFF Health News: A Headless CDC
- GI is exploding with new tech—but how do patients feel about it?
- Maryland physician to pay $500K+ to settle false claims allegations
- Rhode Island oral surgeon launches Congressional campaign
- Premier Anesthesia, City of Hope Phoenix ink partnership
- 20 behavioral health leaders challenge industry assumptions
- What simulation training revealed about GI skills gaps
- Judge dismisses physician’s wrongful termination suit against staffing firm
- 3 California behavioral health centers to close amid funding shifts
- North Carolina practice to close after 40+ years
- St. Tammany opens outpatient cardiology center
- Indiana bars autism therapy provider from Medicaid billing: Wall Street Journal
- 6 dental practice openings to know
- UnitedHealth shareholder sues over proposal to include details on integration in annual proxy
- APRNs, PAs account for most antipsychotic prescriptions for Medicare Part D: Study
- Infosys to acquire Optimum Healthcare IT in $465M deal
- Oklahoma House passes bill expanding scope of dental assistants
- Dr. Nellie Kim-Weroha joins American Association of Orthodontists’ Board of Trustees
- California behavioral health agency to close 2 centers
- 52 DSOs to know: 2026
- DOJ alleges NewYork-Presbyterian forces payers into anticompetitive 'all-or-nothing' contracts
- FDA Warns Biotech Firm Over Cancer Drug Anktiva Claims
- Bees and Hummingbirds May Be Consuming Small Amounts of Alcohol
- Two States Sue Cord Blood Company Over Misleading Claims
- New WHO Guidance Aims To Speed Tuberculosis Testing
- As questions swirl around ATTR competition, Alnylam plots path to market leadership for Amvuttra
- Trump admin delays nomination for new CDC director past deadline
- Outspoken ACIP member steps down amid vaccine panel uncertainty: reports
- Egg-based drugmaker Neion Bio emerges from stealth to cook up multi-product biosimilar collab
- Genentech walks the walk in lupus as sponsor of annual awareness and fundraising event
- Study Reveals How Many Americans Consider Using a Gun
- Massive Study Finds Stress and Grief Don’t Cause Cancer
- Ultra-Processed Foods Harm Fertility In Both Men And Women, Studies Reveal
- Small Daily Habits Can Add Up To Better Heart Health
- Ritalin Might Protect ADHD Kids' Long-Term Mental Health, Study Finds
- Can You Drink Enough Fluids To Prevent Kidney Stones? Maybe Not, New Study Says
- Clasp, loan-linked hiring tool for employers, clinches $20M to expand amid federal loan caps
- Taking a GLP-1? Doctors Say Not To Forget About Movement and Mental Health
- OpenEvidence rolls out AI medical coding feature
- CDC’s Acting Chief Promises a Return to Stability in a Tumultuous Moment
- California peer-run behavioral health center to close amid funding shift
- Remarks at the Financial Stability Oversight Council Meeting
- ‘Integration only works if data lives in the same system’: How 5 systems are operationalizing behavioral health
- Inside UHS’ playbook for responsible behavioral health growth
- Epic4 Specialty Partners adds Illinois practice
- The unsolved problems still plaguing dentistry
- American Dental Association adds mental health, GLP-1 prompts to patient forms
- RWJF: Between 5M and 10M people could lose Medicaid coverage in 2028 under work requirements
- Gen Z nurses prioritize schedule flexibility, need more manager interactions to avoid turnover
- How pharma marketers can capitalize on HCPs’ AI, social media and streaming habits
- Federal Officials Investigate States That Require Abortion Coverage
- Corcept's lead drug bounces back from FDA snub with different approval as Lifyorli in ovarian cancer
- Ionis slashes Tryngolza's price tag by 93% ahead of anticipated label expansion
- FDA approves Denali's Hunter syndrome drug, handing rare disease community a win
- Baby Walkers Sold on Amazon Recalled Over Fall Risk
- Want To Protect Your Brain? Science Says Exercise
- HelloFresh Pizza Recall Issued in 10 States Over Metal Risk
- Clinical Trials Have Too Much Data…That’s the Problem.
- Clinical Trials Have Too Much Data…That’s the Problem.
- CMS reveals new Medicaid model that supports coordination for children with complex needs
- Novartis sued by breast cancer patient over branded drug websites’ data-sharing practices
- Takeda targets $1.3B in cost savings in further restructuring
- Biogen pays $20M upfront to tap into Alteogen's subQ delivery tech
- 'Universal Donor' Blood Supplies Dangerously Low, Study Warns
- Why Stepping Outside May Help You Eat Better
- U.S. Medicine, Science Facing An Online Misinformation Siege, Poll Concludes
- Childhood Obesity Undercuts The American Dream For Some, Study Says
- Inclusive High Schools Benefit All Students, Not Just LGBTQ Teens
- Parental Loss Due to Drugs, Violence Raises Child Death Risk by 2,000%
- As Boehringer touts US launches, board chairman worries EU is 'falling further behind'
- The evolving state of exome and genome sequencing
- An Arm and a Leg: Steep Health Care Costs Steer Americans to Tough Decisions
- Demoralized CDC Workforce Reels From Year of Firings, Funding Cuts, and a Shooting
- Qualified Health locks in $125M in fresh funding to scale enterprise AI at health systems
- Misery Loves [Investment] Company?: Remarks at the 2026 Investment Company Institute Investment Management Conference
- Study: Nearly 1 in 5 pediatric hospital deaths involve sepsis
- As expansions come online, CDMO Hovione aims to meet industry's 'dual supply and sourcing' zeal: exec
- Opening Remarks at the Digital Asset Summit 2026
- CVS Caremark, FTC reach settlement in insulin pricing case
- UCB unveils plan to build $2B biologics plant near its US headquarters in Atlanta
- PeaceHealth sued over plans to tap out-of-state staffer ApolloMD for Oregon EDs
- New Lyme Disease Vaccine Shows Strong Results in Trial
- TrumpRx Adds Diabetes, COPD Drugs at Steep Discounts
- Highmark reports $175M net loss for 2025 as financial headwinds batter health plan
- Listen to the Latest ‘KFF Health News Minute’
- Abivax hires commercial chief from Takeda to infuse Entyvio expertise into IBD launch prep
- ImmunityBio hit with FDA warning letter over Anktiva promotions in TV ad, podcast episode
- Alcohol Prep Pads Recalled Over Bacteria Risk, Cardinal Health Says
- Fewer patients traveled for abortions in 2025 as telehealth care increased, report finds
- Cologuard campaign reunites ‘Full House’ stars to give ‘The Talk’ about colon cancer screening
- Lilly to remove certain insulin products from European markets by 2027
- Karyopharm, looking to jump-start Xpovio, reports mixed results in myelofibrosis
- Study Warns Fluoride Bans May Raise Tooth Decay in Children
- WuXi Bio's record number of new projects in 2025 leaned heavily on US clients
- “Me engañaron”: agentes encadenan a un padre que había ido al ICE a reunirse con sus hijos
- Gilead inks Manta pact to dive deeper into cancer patient support
- Cheap Children's Clothing Tainted With Lead, Study Says
- Insulin Prices Fell For Medicare Patients Under Biden-Era Caps, Study Finds
- New Fathers Face Mental Health Challenges, Study Finds
- Your Choice Of Booze Influences Your Risk Of Death, Study Says
- AI Gets a 'D' When Judging Scientific, Medical Claims
- New Online Tool Helps Parkinson's Patients Weigh Brain Implant Decision
- AI chatbot use for health information up 16% from 2024: Rock Health survey
- ‘They Tricked Me’: A Father Was Chained After He Went to ICE To Reunite With His Kids
- Wilmington PharmaTech commits $50M to US API expansion
- Strides recalls nearly 90K bottles of children's ibuprofen after contamination complaints
- Trump administration unveils national policy framework for AI as it moves to override state laws
- Breast Cancer Locator System Submitted for De Novo 510(k) by Cairn Surgical
- Breast Cancer Locator System Submitted for De Novo 510(k) by Cairn Surgical
- 17 spine surgery firsts in Q1
- 17 spine surgery firsts in Q1
- Cencora acquiring EyeSouth Partners' retina business for $1.1B
- A look at how Optum Rx is using AI to address pharmacy fraud, waste and abuse
- Nursing Homes Accused of False Diagnoses To Hide Drug Use
- FDA Approves Higher-Dose Wegovy To Help People Lose More Weight
- Teens Often Pressured To Send Sexual Photos by Someone They Know, Study Finds
- Nearly 90,000 Bottles of Children’s Ibuprofen Recalled Nationwide
- Rural Residents Have Highest Cancer Death Rates, Researchers Say
- Your Bank Account Might Show How Well Your Brain Will Age, Researchers Say
Executive power is one oft-challenged constitutional provision, among many of our day. This decision says, "Yes, the Constitution means exactly what it says."
Score one for constitutional government and healthcare freedom from academic ideological oppression of the professions.
https://www.powerlineblog.com/archives/2026/02/on-dei-a-victory.php
On DEI, a Victory
At the beginning of his administration, President Trump issued two executive orders directing federal agencies to end DEI programs in federal grant and contract processes. Those orders were challenged by plaintiffs that included the City of Baltimore, the American Association of University Professors and the National Association of Diversity Officers in Higher Education. Those plaintiffs sought, and obtained, a preliminary injunction in the district court, preventing implementation of the President’s orders.
Today the Fourth Circuit Court of Appeals, in a decision by two Obama appointees and a Trump appointee, reversed the district court and allowed the Trump administration to implement the executive orders. As usual, the decision was concerned largely with standing and ripeness issues. When Chief Judge Albert Diaz got to the merits, the court’s reasoning was straightforward:
The President may determine his policy priorities and instruct his agents to make funding decisions based on them. See generally 2 C.F.R. § 200.340(a)(4) (2025). President Trump has decided that equity isn’t a priority in his administration and so has directed his subordinates to terminate funding that supports equity-related projects to the maximum extent allowed by law. Whether that’s sound policy or not isn’t our call. We ask only whether the policy is unconstitutionally vague for funding recipients.
The court then rejected the plaintiffs’ First Amendment argument:
The First Amendment precludes the government from “abridging the freedom of speech.” Reed v. Town of Gilbert, 576 U.S. 155, 163 (2015) (quoting U.S. Const. amend. I). So generally, “the government may not regulate speech based on its substantive content or the message it conveys.” Rosenberger v. Rector & Visitors of Univ. of Va., 515 U.S. 819, 828 (1995).
But this case arises in the funding context. There, as we’ve explained, the government “has wide latitude to set spending priorities” and “to ch[oose] to fund one activity to the exclusion of the other.” Finley, 524 U.S. at 588 (citation modified). But again, the latitude isn’t limitless. …
To start, to make out a First Amendment claim, “[p]laintiffs must show that the certification requirement impermissibly restricts their ability to engage in protected speech.” Nat’l Urban League, 783 F. Supp. 3d at 102. But the Provision [the portion of the executive order at issue] requires only that plaintiffs certify compliance with federal antidiscrimination laws, which the First Amendment doesn’t confer a right to violate. See S.F. AIDS Found., 786 F. Supp. 3d at 1222 (“[W]hile the First Amendment may protect speech that advocates for violation of law, it does not protect activities that directly violate antidiscrimination law.”). Put another way, plaintiffs have no protectable speech interest in operating, and “no constitutional right to operate[,] DEI programs that violate federal antidiscrimination law.” Nat’l Urban League, 783 F. Supp. 3d at 102.
This wasn’t a close case. Is there any serious question that the Executive Branch, in directing grants, can adhere to the priorities of the Executive Branch? And how can it be controversial to require grant recipients to certify that they are not violating federal antidiscrimination law?
And yet, these plaintiffs won in the trial court, and were supported on appeal by an array of amici that included 18 states and a number of private employers, along with other organizations–the establishment, in effect. Basically, these parties argued for the proposition that the federal government must adhere to liberal ideology, no matter what the electorate might vote for, and no matter what the Constitution and federal law may provide. That is, indeed, the Democratic Party’s position, and it was expressed starkly in this case.
That view has been defeated, at least for the moment, and the Executive Branch has been freed to do what Americans voted for. It should be noted, however, that liberals, through their frivolous lawsuit and with the connivance of a Democratic Party judge, delayed for a year implementation of the Trump administration’s requirement that federal grantees not engage in illegal discrimination.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.


















